qSOFA Score: Clinical Criteria and Sepsis Screening

The qSOFA (quick Sequential Organ Failure Assessment) score is a bedside screening tool that uses three clinical criteria to flag patients who may be deteriorating from sepsis: a respiratory rate of 22 breaths per minute or higher, a systolic blood pressure of 100 mmHg or lower, and an altered level of consciousness (defined as a Glasgow Coma Scale score of 13 or less). Each criterion scores one point, for a total range of 0 to 3; a score of 2 or more suggests higher risk.

Where the Score Came From

The qSOFA was introduced in 2016 as part of the Sepsis-3 consensus definitions, which redefined sepsis as life-threatening organ dysfunction caused by a dysregulated response to infection. The task force that developed it analyzed a large retrospective database and distilled the three-variable model from a broader set of clinical measures, selecting the combination that best predicted poor outcomes outside the ICU.

¹ The appeal was simplicity: unlike the full SOFA score, which requires lab results like bilirubin, creatinine, and platelet counts, qSOFA needs nothing more than a blood pressure cuff and a stethoscope. A nurse, paramedic, or physician can calculate it in under a minute at the bedside.

That simplicity is both the score’s greatest strength and the source of most criticism directed at it. Three variables capture only a fraction of the physiological chaos that sepsis causes, and the research since 2016 has painted a complicated picture of where qSOFA helps and where it falls short.

The Sensitivity Problem

The most consistent finding across studies is that qSOFA is specific but not sensitive. In plain terms, when the score is positive (2 or higher), the patient is very likely in real trouble. But a large number of patients who do have sepsis will score below that threshold and be missed. A meta-analysis pooling data from studies of patients with suspected sepsis found that qSOFA’s specificity was about 0.82, while its sensitivity was only 0.46. By contrast, the older SIRS criteria (which flag fever, elevated heart rate, fast breathing, or abnormal white blood cell count) caught about 82% of cases but with a specificity of just 0.24, meaning they flagged enormous numbers of patients who did not have sepsis.

²

A separate systematic review confirmed the pattern: SIRS was more sensitive for diagnosing sepsis, while qSOFA was more specific, and qSOFA was the better predictor of in-hospital mortality.

³ This distinction matters enormously in practice. A screening tool you use to catch sepsis early ideally should not miss more than half the cases. qSOFA was never designed to be a diagnostic test for sepsis; it was designed to identify patients at higher risk of dying from it. Those are different jobs, and much of the controversy around the score stems from conflating the two.

Predicting Death Versus Detecting Sepsis

When the question shifts from “does this patient have sepsis?” to “is this patient likely to die?”, qSOFA looks better. In a study of surgical patients on intermediate care and general wards, qSOFA outperformed both SIRS and the full SOFA score for predicting hospital mortality, with an area under the curve of 0.82 compared to 0.72 for SIRS and 0.63 for SOFA.

⁴ A prospective ward-based study found similar results: qSOFA had better prognostic value for mortality than SIRS (area under the curve 0.86 versus 0.67), even though its sensitivity for detecting sepsis was far lower (53% versus 98%).⁵

However, once patients reach the ICU, the picture shifts. Among critically ill patients already receiving intensive monitoring, tools that incorporate lab values tend to perform better. One study of ICU patients with sepsis and septic shock found that the full SOFA score had the highest accuracy for predicting hospital mortality (area under the curve 0.88), with qSOFA close behind at 0.85.

⁶ The takeaway is that qSOFA adds the most value early in the clinical encounter, before lab results are available, and in settings where the full SOFA score cannot be easily calculated.

How It Performs in the Emergency Department

The emergency department is where qSOFA was expected to shine, since clinicians need fast triage decisions and may not yet have laboratory data. The reality has been disappointing to many researchers. In a large ED sepsis database, the sensitivity of qSOFA calculated at the moment of triage was just 33% for predicting in-hospital mortality. Even the maximum qSOFA recorded during the entire ED stay only reached 69%, which did not significantly outperform a simple initial lactate measurement.

⁷

When compared head-to-head with the National Early Warning Score (NEWS) and SIRS in an ED population, qSOFA came in last for detecting sepsis and septic shock, with a sensitivity of about 29% versus 84% for NEWS and 86% for SIRS. Its specificity was nearly 99%, meaning almost no false alarms, but a tool that misses seven out of ten sepsis cases is hard to rely on as a primary screen.

⁸ A prospective Swedish study reported a similarly bleak figure: qSOFA identified only about a third of patients with severe sepsis at triage, while an established triage system caught 85%.⁹

One nuance worth noting is that qSOFA’s performance for mortality prediction in non-ICU settings can vary by the type of infection. A validation study across different infection foci found that qSOFA’s area under the curve for mortality ranged from 0.83 in a mixed-infection group down to 0.57 in patients with skin and soft tissue infections, though the difference did not reach statistical significance.

¹⁰

An Uncomfortable Finding About Infection Specificity

One of the assumptions behind qSOFA is that it helps clinicians distinguish infected patients who are at risk of deteriorating. But a large multicenter study across hospitals in California and Illinois found that qSOFA performed no better in patients with infection than in those without. In other words, the score seems to flag sick patients in general, not specifically septic ones. The NEWS and MEWS scoring systems outperformed both qSOFA and SIRS for predicting death across the full cohort.

¹¹

A separate analysis of non-ICU patients with and without infection reached the same conclusion: qSOFA often performed worse in patients with infection than in general ward patients.

¹² This is a genuinely awkward result for a score whose name contains “sepsis.” It suggests qSOFA is better understood as a general acuity marker than as a sepsis-specific screen.

General Wards and the Question of Clinical Deterioration

Outside the ED, general hospital wards are another setting where early warning of deterioration could save lives. Here, the Modified Early Warning Score (MEWS) consistently outperforms qSOFA. A Korean study of general ward patients found that MEWS was significantly better at predicting clinical deterioration, in-hospital cardiac arrest, and unexpected ICU transfer, regardless of whether the patient had a suspected infection.

¹³ This aligns with the broader evidence that multi-parameter early warning scores, which incorporate more vital sign components including temperature and heart rate, tend to outperform qSOFA’s deliberately stripped-down three variables for general ward surveillance.

Prehospital Use by Paramedics

Because qSOFA requires no lab work, it is a natural candidate for use by ambulance crews. The evidence here is mixed but interesting. A study of over 2,200 adult medical patients transported by ambulance found that prehospital qSOFA had a sensitivity of just 43% for sepsis and 41% for in-hospital mortality, but its specificity was above 90% for both. Higher scores were strongly associated with sepsis diagnosis, mortality, and triage to higher-acuity zones.

¹⁴

A retrospective cohort study further confirmed that being qSOFA-positive in the prehospital setting roughly doubled the hazard of in-hospital death, even after adjusting for age, sex, and chronic health conditions.

¹⁵ And there may be a process-of-care benefit: a study of prehospital qSOFA documentation found that recording a respiratory rate of 22 or more and altered mentation in the field independently predicted earlier antibiotic and fluid administration in the hospital.

¹⁶

Whether prehospital qSOFA actually changes patient outcomes remains unresolved. A prospective study that implemented a qSOFA-based triage protocol in an emergency department found a modest but non-significant increase in the proportion of sepsis patients receiving antibiotics within one hour, and no meaningful difference in ICU admissions or mortality.

¹⁷

Repeated Measurements Over Time

Most studies evaluate qSOFA as a single snapshot at triage or admission. But sepsis is a dynamic process, and a patient’s status can change rapidly. Research on serial qSOFA measurements suggests that tracking the score over time substantially improves its predictive power. A large study found that the mean qSOFA at 48 hours had an area under the curve of 0.86 for predicting mortality, compared to 0.79 for the initial score alone. Using trajectory modeling, the researchers identified five patterns of qSOFA change (always low, increasing, decreasing, moderate, and always high) that further improved prediction.

¹⁸

A study tracking serial scores in the ED found that qSOFA’s accuracy for predicting a rise in organ dysfunction was highest at four hours after triage, though the differences between time points were not always statistically significant.

¹⁹ The clinical implication is straightforward: a single qSOFA at the door tells you something, but repeated assessments tell you more. A patient who starts with a score of 0 and climbs to 2 is on a different trajectory than one who starts at 2 and drops to 0.

Adding Lactate to Improve Accuracy

One of the most studied modifications is combining qSOFA with a point-of-care lactate measurement. Lactate is a marker of tissue hypoperfusion that rises when oxygen delivery cannot keep up with demand, a hallmark of septic shock. A large prospective study in Southeast Asia found that a combined qSOFA-lactate score had significantly better discrimination for 28-day mortality than qSOFA alone (area under the curve of 0.78 versus 0.68) and performed comparably to a modified SOFA score.

²⁰

A systematic review and meta-analysis of this lactate-enhanced qSOFA (sometimes called LqSOFA) across over 23,000 sepsis patients found a sensitivity of 0.61 and specificity of 0.81, with an area under the curve of about 0.81. The odds of mortality among patients with a positive LqSOFA were roughly seven times higher than among those with a negative score.

²¹ This modification partly addresses qSOFA’s sensitivity gap without requiring the full panel of lab tests that SOFA demands. Where point-of-care lactate devices are available, the combination appears to be a meaningful upgrade.

Low- and Middle-Income Countries

qSOFA’s appeal is arguably strongest in resource-limited settings where lab-dependent scoring systems are impractical. A systematic review focused on low- and middle-income countries found pooled sensitivity of 0.70, specificity of 0.73, and an area under the curve of 0.77 for sepsis diagnosis.

²² A more recent meta-analysis focused specifically on resource-limited settings reported slightly different numbers: sensitivity of 0.51, specificity of 0.83, and an area under the curve of 0.74, with a positive likelihood ratio of 3.0 and a negative likelihood ratio of 0.59. The authors concluded that qSOFA had moderate rule-in ability but limited rule-out utility and should not be used as a standalone screening tool.

²³

The practical takeaway for clinicians working without ready access to laboratories is that qSOFA can help prioritize patients for closer attention, but a negative score should not be taken as reassurance. In settings where NEWS can be calculated (it requires a pulse oximeter and thermometer in addition to what qSOFA needs), the two tools perform comparably, and NEWS may offer a slight edge.

Pregnancy and Pediatrics

Standard qSOFA thresholds were derived from adult non-pregnant populations, and they do not translate well to either pregnant women or children. Pregnancy normally lowers blood pressure and raises respiratory rate, which means the standard cutoffs can both over-trigger on healthy pregnant patients and miss genuinely ill ones. A study of 104 pregnant patients with severe infections found that the standard qSOFA had an area under the curve of just 0.54 for predicting severe maternal morbidity, which is barely better than a coin flip. A pregnancy-adapted version (called qSOFA-P) that raised the respiratory rate threshold to 35 breaths per minute and lowered the systolic blood pressure cutoff to 85 mmHg jumped to an area under the curve of 0.77, with sensitivity improving from 38% to 79%.

²⁴

A larger WHO study of obstetric patients confirmed that the obstetric-modified qSOFA (OmqSOFA) had low sensitivity (38%) with high specificity (90%) for severe maternal outcomes.

²⁵ For pregnant patients, the bottom line is that standard qSOFA is unreliable, and pregnancy-specific modifications are needed but still under active study.

In children, the issue is different: normal vital sign ranges change dramatically with age. A two-year-old’s normal respiratory rate would score positive on the adult qSOFA. Several groups have developed age-adapted versions that adjust thresholds to pediatric norms. A multicenter ICU study found that age-adapted SOFA and the PELOD-2 score both outperformed age-adapted qSOFA for predicting mortality in children with suspected infection (areas under the curve of about 0.83 and 0.82 versus 0.74 for qSOFA).

²⁶ Age-adapted qSOFA has shown more promising results in ED and general pediatric settings, but the evidence base is still relatively thin, and pediatric sepsis definitions have continued to evolve independently of the adult framework.

²⁷

Where qSOFA Fits in Current Practice

The Surviving Sepsis Campaign’s 2021 guidelines did not recommend qSOFA as a stand-alone screening tool for sepsis, partly because of the sensitivity concerns described above. The guidelines instead suggest that hospitals use locally validated screening protocols, which may incorporate qSOFA alongside other tools. In practice, many hospitals use qSOFA as one input among several, layering it with lactate levels, NEWS or MEWS scores, and clinical judgment rather than relying on it as a sole trigger for sepsis alerts.

Electronic health record systems have started incorporating automated qSOFA calculation into clinical dashboards, alerting nurses and physicians when a patient crosses the threshold of 2. The real-world impact of these automated alerts is still being evaluated. The evidence so far suggests that the alerts may prompt earlier attention to deteriorating patients, but the translation into improved hard outcomes like mortality remains uncertain. The combination of high specificity and low sensitivity means these systems will miss many at-risk patients while rarely crying wolf, a trade-off that may be acceptable in some institutional workflows but dangerous as a sole safety net.

For clinicians making sense of the alphabet soup, the practical hierarchy looks roughly like this: if you have nothing but a blood pressure cuff and your own observations, qSOFA gives you useful information, especially about prognosis. If you have a pulse oximeter and thermometer, NEWS or MEWS will generally outperform it. If you have lab results, the full SOFA score is more powerful. And if you can add a point-of-care lactate, combining it with qSOFA partially closes the sensitivity gap without requiring a full lab panel. No single score replaces clinical suspicion, and a patient who looks sick but scores low on any scale still needs evaluation.